Literature DB >> 11389795

Medical therapy for acute ischemic stroke.

L B Goldstein1.   

Abstract

Over the past decade, there has been an explosion in data related to the treatment of patients with acute ischemic stroke. Thrombolytic therapy with intravenous tissue plasminogen activator has revolutionized the approach to stroke treatment. Intra-arterial administration of thrombolytic agents is also being investigated and is now being used on a compassionate basis. Medical management can have a large impact on stroke-related outcomes, even in patients who do not receive thrombolytic therapy.

Entities:  

Mesh：

Year:  2001        PMID： 11389795     DOI： 10.1007/s11883-001-0023-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  62 in total

1.  Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

Authors:  A Bruno; J Biller; H P Adams; W R Clarke; R F Woolson; L S Williams; M D Hansen
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

2.  Intra-arterial thrombolysis for perioperative stroke after open heart surgery.

Authors:  I L Katzan; T J Masaryk; A J Furlan; C A Sila; J Perl; J C Andrefsky; D M Cosgrove; J F Sabik; P M McCarthy
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

3.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

4.  Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

5.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

6.  Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

Authors:  H P Adams; T G Brott; A J Furlan; C R Gomez; J Grotta; C M Helgason; T Kwiatkowski; P D Lyden; J R Marler; J Torner; W Feinberg; M Mayberg; W Thies
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

7.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

8.  Hazards of therapy for excessive hypertension in acute stroke.

Authors:  M Britton; U de Faire; C Helmers
Journal:  Acta Med Scand       Date:  1980

9.  North Carolina stroke prevention and treatment facilities survey: rtPA therapy for acute stroke.

Authors:  L B Goldstein; L A Hey; R Laney
Journal:  Stroke       Date:  1998-10       Impact factor: 7.914

Review 10.  Hypothermia as a potential treatment for cerebral ischemia.

Authors:  J Maher; V Hachinski
Journal:  Cerebrovasc Brain Metab Rev       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.